|
|
Science Sparks @ ACTREC
|
1st September 2025 |
Vol. No. 14 ; Issue No.698 |
|
|
|
Interesting Reads
|
Grist E, Dutey-Magni P, Parry MA, Mendes L, Sachdeva A, Proudfoot JA, Hamid AA, Ismail M, Howlett S, Friedrich S, DePaula Oliveira L, Murphy L, Brawley C, Dairo O, Lall S, Liu Y, Wetterskog D, Wingate A, Nowakowska K, Zakka L, Amos CL, Atako NB, Wang V, Rush HL, Jones RJ, Leung H, Cross WR, Gillessen S, Parker CC, Marafioti T, Urbanucci A, Fittall M, Schaeffer EM, Spratt DE, Waugh D, Powles T, Sydes MR, Feng FY, Berney DM, Parmar MKB, Clarke NW, Davicioni E, Lotan TL, Sweeney CJ, Brown LC, James ND, Attard G (2025). Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers. Cell.
|
|
Video of the Week
|
|
Innovations in Radiation Therapy for Lung Cancer |
|
|
|
|
|
|
Do You Know?
In 1996, FDA approved anastrozole (Arimidex) as a treatment for breast cancer. This drug blocks the production of estrogen.
|
|
|
Cancer News
|
|
Unlocking the immune system: Cellular 'toolkit' could reprogram cells for cancer therapy
|
MedicalXpress, 29/08/2025
|
The team of researchers has carried out a systematic mapping of the routes to dendritic cell identity. By testing 70 different transcription factors and seeing how they could reprogram ordinary cells into dendritic cells, they identified two distinct toolkits that reprogrammed skin or cancer cells into powerful dendritic...
|
|
|
|
|
|
|
|
|
| -
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|